ReviewCancer treatment reviews2020

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer.

Tzu-Ting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.